2018
DOI: 10.3390/ijms19030671
|View full text |Cite
|
Sign up to set email alerts
|

Hippocampal MicroRNAs Respond to Administration of Antidepressant Fluoxetine in Adult Mice

Abstract: Current antidepressant treatments to anxiety and depression remain inadequate, burdened by a significant percentage of misuse and drug side-effects, due to unclear mechanisms of actions of antidepressants. To better understand the regulatory roles of antidepressant fluoxetine-related drug reactions, we here investigate changes of expression levels of hippocampal microRNAs (miRNAs) after administration of fluoxetine in normal adult mice. We find that 64 miRNAs showed significant changes between fluoxetine treat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
12
0

Year Published

2019
2019
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 66 publications
2
12
0
Order By: Relevance
“…These results in part suggest that antidepressant treatment does not totally reverse chronic stress pathology, but rather cause novel alteration. Similar to our study, Miao N [38] found enrichment of target antidepressant-altered miRNA in axon guidance pathways, emphasizing roles of this pathway in antidepressant therapy.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…These results in part suggest that antidepressant treatment does not totally reverse chronic stress pathology, but rather cause novel alteration. Similar to our study, Miao N [38] found enrichment of target antidepressant-altered miRNA in axon guidance pathways, emphasizing roles of this pathway in antidepressant therapy.…”
Section: Discussionsupporting
confidence: 90%
“…As we can see, only a quarter of treatment-related DE-miRNAs (2/8) overlaps with depressed-related DE-miRNAs. Consistent with this idea, Zhou M [37] studied the miRNA alteration in rats hippocampus caused by CUMS, whereas Miao N [38] and Yang X [39] studied alteration caused by Fluoxetine/Ketamine in the same region, and their results have little overlap. Pan B [40] carried out a similar study with Duloxetine, and the little converging result is found despite miR-124, a well-studied miRNA involved in depression [41] and antidepressant treatment [42].…”
Section: Discussionmentioning
confidence: 97%
“…Our results are consistent with previous studies that report an upregulation of miR-26a after antidepressant treatments in different brain regions, including the dorsal raphe nuclei, while knocking it down increased anxiety [20]. Another study showed that a fluoxetine treatment increased miR-26b levels in mice hippocampi, while miR-26a showed a nonsignificant increase [55]. MiR-26a and miR-26b were also increased in the blood of depressed patients undergoing treatment with the antidepressant escitalopram [21].…”
Section: Repetitive Stress and Mir-26asupporting
confidence: 92%
“…Peng et al indicated that miR-346-5p regulates Wnt/ β -catenin signaling to reduce the expression of downstream genes including c-Myc, CyclinD1, LEF-1, and TCF-1 and subsequent osteogenic differentiation of BMSCs [ 12 ]. Miao et al found that miR-346-5p regulates the differentiation and proliferation of neuronal stem cells by regulating KLF4 expression [ 13 ]. However, the function of miR-346-5p in osteogenic differentiation of BMSCs is still not clear.…”
Section: Introductionmentioning
confidence: 99%